• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素CB1受体的阴阳两面:免疫细胞中CB1缺失会加剧肥胖,而非免疫细胞中CB1缺失则会减轻肥胖。

Yin and yang of cannabinoid CB1 receptor: CB1 deletion in immune cells causes exacerbation while deletion in non-immune cells attenuates obesity.

作者信息

Miranda Kathryn, Becker William, Busbee Philip B, Dopkins Nicholas, Abdulla Osama A, Zhong Yin, Zhang Jiajia, Nagarkatti Mitzi, Nagarkatti Prakash S

机构信息

Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA.

Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

出版信息

iScience. 2022 Aug 24;25(9):104994. doi: 10.1016/j.isci.2022.104994. eCollection 2022 Sep 16.

DOI:10.1016/j.isci.2022.104994
PMID:36093055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9460165/
Abstract

While blockade of cannabinoid receptor 1 (CB1) has been shown to attenuate diet-induced obesity (DIO), its relative role in different cell types has not been tested. The current study investigated the role of CB1 in immune vs non-immune cells during DIO by generating radiation-induced bone marrow chimeric mice that expressed functional CB1 in all cells except the immune cells or expressed CB1 only in immune cells. CB1 recipient hosts were resistant to DIO, indicating that CB1 in non-immune cells is necessary for induction of DIO. Interestingly, chimeras with CB1 in immune cells showed exacerbation in DIO combined with infiltration of bone-marrow-derived macrophages to the brain and visceral adipose tissue, elevated food intake, and increased glucose intolerance. These results demonstrate the opposing role of CB1 in hematopoietic versus non-hematopoietic cells during DIO and suggests that targeting immune CB1 receptors provides a new pathway to ameliorate obesity and related metabolic disorders.

摘要

虽然已证明对大麻素受体1(CB1)进行阻断可减轻饮食诱导的肥胖(DIO),但其在不同细胞类型中的相对作用尚未得到验证。本研究通过生成辐射诱导的骨髓嵌合小鼠,研究了DIO期间CB1在免疫细胞与非免疫细胞中的作用,这些小鼠在除免疫细胞外的所有细胞中表达功能性CB1,或仅在免疫细胞中表达CB1。CB1受体宿主对DIO具有抗性,这表明非免疫细胞中的CB1是诱导DIO所必需的。有趣的是,免疫细胞中含有CB1的嵌合体在DIO中表现出病情加重,同时骨髓来源的巨噬细胞浸润到大脑和内脏脂肪组织,食物摄入量增加,葡萄糖耐量降低。这些结果证明了DIO期间CB1在造血细胞与非造血细胞中的相反作用,并表明靶向免疫CB1受体为改善肥胖及相关代谢紊乱提供了一条新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/67bc4ed85fab/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/d4f0e5c6aa3f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/c3a0ee68e0f4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/b74b97ffdb18/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/d58146968a41/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/44befc61d3e7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/67bc4ed85fab/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/d4f0e5c6aa3f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/c3a0ee68e0f4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/b74b97ffdb18/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/d58146968a41/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/44befc61d3e7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f7b/9460165/67bc4ed85fab/gr5.jpg

相似文献

1
Yin and yang of cannabinoid CB1 receptor: CB1 deletion in immune cells causes exacerbation while deletion in non-immune cells attenuates obesity.大麻素CB1受体的阴阳两面:免疫细胞中CB1缺失会加剧肥胖,而非免疫细胞中CB1缺失则会减轻肥胖。
iScience. 2022 Aug 24;25(9):104994. doi: 10.1016/j.isci.2022.104994. eCollection 2022 Sep 16.
2
Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity.微小 RNA 在 CB1 拮抗剂介导的饮食诱导肥胖期间脂肪组织巨噬细胞极化和趋化作用中的作用。
J Biol Chem. 2019 May 10;294(19):7669-7681. doi: 10.1074/jbc.RA118.005094. Epub 2019 Mar 25.
3
Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.抑制大麻素受体1可影响饮食诱导肥胖小鼠的脂质代谢。
Biochemistry (Mosc). 2018 Oct;83(10):1279-1287. doi: 10.1134/S0006297918100127.
4
Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells.大麻素受体 1 阻断通过巨噬细胞中 miR-30e-5p 对 Delta-Like-4 的调节,减轻肥胖和脂肪组织 1 型炎症,从而下调 Th1 细胞。
Front Immunol. 2019 May 10;10:1049. doi: 10.3389/fimmu.2019.01049. eCollection 2019.
5
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.在外周而非中枢,CB1拮抗剂在饮食诱导的肥胖大鼠中提供不依赖食物摄入的代谢益处。
Diabetes. 2008 Nov;57(11):2977-91. doi: 10.2337/db08-0161. Epub 2008 Aug 20.
6
A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.一种新型外周大麻素 1 受体拮抗剂 AJ5012 可改善肥胖小鼠的代谢结果并抑制脂肪组织炎症。
FASEB J. 2019 Mar;33(3):4314-4326. doi: 10.1096/fj.201801152RR. Epub 2018 Dec 19.
7
A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.一种新型外周大麻素受体 1 拮抗剂,BPR0912,可独立于食物摄入减少体重并调节产热。
Diabetes Obes Metab. 2015 May;17(5):495-504. doi: 10.1111/dom.12447. Epub 2015 Feb 25.
8
Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.外周型大麻素 1 型受体阻断剂可恢复下丘脑瘦素信号转导。
Mol Metab. 2017 Oct;6(10):1113-1125. doi: 10.1016/j.molmet.2017.06.010. Epub 2017 Jun 24.
9
Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice.大麻素受体 1(CB1)拮抗剂增强肥胖小鼠的葡萄糖利用并激活棕色脂肪组织。
Diabetologia. 2011 Dec;54(12):3121-31. doi: 10.1007/s00125-011-2302-6. Epub 2011 Oct 11.
10
The role of the endocannabinoid system in the control of energy homeostasis.内源性大麻素系统在能量平衡控制中的作用。
Int J Obes (Lond). 2006 Apr;30 Suppl 1:S33-8. doi: 10.1038/sj.ijo.0803276.

引用本文的文献

1
Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation.大麻素补充剂的肾脏结局及其他不良反应
Nutrients. 2024 Dec 27;17(1):59. doi: 10.3390/nu17010059.
2
Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species.Δ9-四氢大麻酚通过消除活性氧来阻断骨髓来源的巨噬细胞分化。
Antioxidants (Basel). 2024 Jul 23;13(8):887. doi: 10.3390/antiox13080887.
3
Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges.

本文引用的文献

1
Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice.外周选择性CB1受体拮抗剂改善小鼠代谢综合征症状。
ACS Pharmacol Transl Sci. 2021 Mar 9;4(2):757-764. doi: 10.1021/acsptsci.0c00213. eCollection 2021 Apr 9.
2
Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.阻断外周 CB1 受体可逆转小鼠饮食诱导的肝脂肪变性,其作用依赖于 p53/miRNA-22/SIRT1/PPARα。
Mol Metab. 2020 Dec;42:101087. doi: 10.1016/j.molmet.2020.101087. Epub 2020 Sep 26.
3
CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice.
用医用大麻支持晚期癌症患者的肠道健康:潜在的益处和挑战。
Br J Cancer. 2024 Jan;130(1):19-30. doi: 10.1038/s41416-023-02466-w. Epub 2023 Oct 26.
4
Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity.探索大麻素受体拮抗剂在炎症、糖尿病和肥胖症中的治疗潜力。
Biomedicines. 2023 Jun 8;11(6):1667. doi: 10.3390/biomedicines11061667.
5
CB Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity.CB 配体 AM251 可诱导肥胖饮食诱导的肥胖症除了增加全身炎症外还可引起体重减轻和脂肪减少。
Int J Mol Sci. 2022 Sep 28;23(19):11447. doi: 10.3390/ijms231911447.
大麻素受体 2 激动剂 JWH-133 通过核因子红细胞 2 相关因子 2/血红素加氧酶-1 途径抑制肥胖诱导的 M1 型巨噬细胞极化,从而减轻慢性炎症。
Life Sci. 2020 Nov 1;260:118424. doi: 10.1016/j.lfs.2020.118424. Epub 2020 Sep 17.
4
Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production.大麻素受体2的激活通过在白细胞介素-22产生上游使髓样细胞失活来预防结肠炎相关的结肠癌。
iScience. 2020 Aug 27;23(9):101504. doi: 10.1016/j.isci.2020.101504. eCollection 2020 Sep 25.
5
Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity.在暴露于葡萄球菌肠毒素B后给予Δ9-四氢大麻酚(THC)可保护小鼠免受急性呼吸窘迫综合征和毒性的影响。
Front Pharmacol. 2020 Jun 16;11:893. doi: 10.3389/fphar.2020.00893. eCollection 2020.
6
Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells.大麻素受体 1 阻断通过巨噬细胞中 miR-30e-5p 对 Delta-Like-4 的调节,减轻肥胖和脂肪组织 1 型炎症,从而下调 Th1 细胞。
Front Immunol. 2019 May 10;10:1049. doi: 10.3389/fimmu.2019.01049. eCollection 2019.
7
Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity.微小 RNA 在 CB1 拮抗剂介导的饮食诱导肥胖期间脂肪组织巨噬细胞极化和趋化作用中的作用。
J Biol Chem. 2019 May 10;294(19):7669-7681. doi: 10.1074/jbc.RA118.005094. Epub 2019 Mar 25.
8
Diet-Induced Obesity in Cannabinoid-2 Receptor Knockout Mice and Cannabinoid Receptor 1/2 Double-Knockout Mice.饮食诱导的大麻素 2 型受体敲除小鼠和大麻素受体 1/2 双敲除小鼠肥胖。
Obesity (Silver Spring). 2019 Mar;27(3):454-461. doi: 10.1002/oby.22403. Epub 2019 Jan 30.
9
Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Users.使用者体重指数降低和肥胖率降低的理论解释。
Cannabis Cannabinoid Res. 2018 Dec 21;3(1):259-271. doi: 10.1089/can.2018.0045. eCollection 2018.
10
MicroRNA-30 modulates metabolic inflammation by regulating Notch signaling in adipose tissue macrophages.miRNA-30 通过调节脂肪组织巨噬细胞中的 Notch 信号转导来调节代谢性炎症。
Int J Obes (Lond). 2018 Jun;42(6):1140-1150. doi: 10.1038/s41366-018-0114-1. Epub 2018 Jun 13.